Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
Notified -
Globe Newswire24-03-2025, 10:53
Deriv nhận Chứng nhận Vàng từ Tổ chức Investors in People 19-04-2023, 21:58